Playback speed
10 seconds
2020 SOHO Highlights De-Intensified vs. Intensified Treatment in Ph+ ALL: What Are the Long Term EFS/OS Outcomes? What Is the MRD Negativity Rate With Dasatinib and Blinatumomab?
13 views
November 13, 2020
Login to view comments.
Click here to Login
Leukemia